BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20403707)

  • 21. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
    Braundmeier AG; Nowak RA
    Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of soluble interleukin (IL)-6 receptor in mediating the effects of IL-6 on matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression by gingival fibroblasts.
    Irwin CR; Myrillas TT; Traynor P; Leadbetter N; Cawston TE
    J Periodontol; 2002 Jul; 73(7):741-7. PubMed ID: 12146533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
    Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
    Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of hesperetin on the production of inflammatory mediators in IL-1beta treated human synovial cells.
    Choi EM; Lee YS
    Cell Immunol; 2010; 264(1):1-3. PubMed ID: 20538267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy.
    Corps AN; Harrall RL; Curry VA; Fenwick SA; Hazleman BL; Riley GP
    Arthritis Rheum; 2002 Nov; 46(11):3034-40. PubMed ID: 12428247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmentation of type I IL-1 receptor expression and IL-1 signaling by IL-6 and glucocorticoid in murine hepatocytes.
    Ito A; Takii T; Matsumura T; Onozaki K
    J Immunol; 1999 Apr; 162(7):4260-5. PubMed ID: 10201956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
    Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
    Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FK506 suppresses the stimulation of matrix metalloproteinase 13 synthesis by interleukin-1beta in rheumatoid synovial fibroblasts.
    Migita K; Miyashita T; Maeda Y; Aoyagi T; Kawabe Y; Nakamura M; Yatsuhashi H; Ishibashi H; Eguchi K
    Immunol Lett; 2005 May; 98(2):194-9. PubMed ID: 15860218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
    Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
    J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
    Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE
    Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
    Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes.
    Igaz P; Tóth S; Rose-John S; Madurka I; Fejér G; Szalai C; Falus A
    Cytokine; 1998 Aug; 10(8):620-6. PubMed ID: 9722935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel role of IL-6/SIL-6R signaling in the expression of inducible nitric oxide synthase (iNOS) in murine B16, metastatic melanoma clone F10.9, cells.
    Kang KW; Wagley Y; Kim HW; Pokharel YR; Chung YY; Chang IY; Kim JJ; Moon JS; Kim YK; Nah SY; Kang HS; Oh JW
    Free Radic Biol Med; 2007 Jan; 42(2):215-27. PubMed ID: 17189827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes.
    François M; Richette P; Tsagris L; Fitting C; Lemay C; Benallaoua M; Tahiri K; Corvol MT
    Arthritis Rheum; 2006 Apr; 54(4):1233-45. PubMed ID: 16572457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoblastoma suppression of matrix metalloproteinase 1, but not interleukin-6, through a p38-dependent pathway in rheumatoid arthritis synovial fibroblasts.
    Bradley K; Scatizzi JC; Fiore S; Shamiyeh E; Koch AE; Firestein GS; Gorges LL; Kuntsman K; Pope RM; Moore TL; Han J; Perlman H
    Arthritis Rheum; 2004 Jan; 50(1):78-87. PubMed ID: 14730602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imidaprilat inhibits matrix metalloproteinase-2 activity in human cardiac fibroblasts induced by interleukin-1beta via NO-dependent pathway.
    Guo XG; Uzui H; Mizuguchi T; Ueda T; Chen JZ; Lee JD
    Int J Cardiol; 2008 Jun; 126(3):414-20. PubMed ID: 18192036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors influencing the effect of the soluble IL-6 receptor on IL-6 responses in HepG2 hepatocytes.
    Paysant J; Blanqué R; Vasse M; Soria C; Soria J; Gardner CR
    Cytokine; 2000 Jun; 12(6):774-9. PubMed ID: 10843763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes.
    Gabay C; Silacci P; Genin B; Mentha G; Le Coultre C; Guerne PA
    Eur J Immunol; 1995 Aug; 25(8):2378-83. PubMed ID: 7545121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1beta mediates proliferation and differentiation of multipotent neural precursor cells through the activation of SAPK/JNK pathway.
    Wang X; Fu S; Wang Y; Yu P; Hu J; Gu W; Xu XM; Lu P
    Mol Cell Neurosci; 2007 Nov; 36(3):343-54. PubMed ID: 17822921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.